Loading post…
AnthropicAnnouncement
Apply for Anthropic’s AI for Science rare disease research grants
Summary
Anthropic’s AI for Science program is accepting applications for a rare genetic disease research call, offering accepted applicants up to $50,000 in Claude credits over six months across two tracks: basic science and early-stage biotechnology. The basic-science track focuses on collaboration and mechanism discovery, including work with the Monarch Initiative’s Mondo Disease Ontology, Monarch Knowledge Graph, and agent-friendly DisMech library. The biotech track targets faster therapeutic development through regulatory documentation, modality and target analysis, biomarker discovery, and potential basket-trial strategies. Applications are open through August 2, 2026, at 11:59 PM PST, and projects may use Claude Opus or other approved generally available biology models.
Context
Rare diseases affect scattered small populations, which makes it difficult to build patient registries, identify therapeutic targets, design clinical trials, and detect mechanisms shared across diseases. Drug development also faces delays from manufacturing queues, sequential safety studies, and extensive regulatory documentation.
Approach / What changed
The program offers two grant tracks: one supporting collaboration among clinical researchers, patient organizations, and data scientists for basic science, and another supporting biotechnologists and early-stage biotechs in accelerating therapeutic development. Applicants receive API credits and access to approved Claude models, while projects may use resources such as Mondo, the Monarch Knowledge Graph, and DisMech.
Takeaways
Accepted applicants can receive up to $50,000 in Claude credits over six months, with applications due August 2, 2026, at 11:59 PM PST.
Track-one outputs will be made publicly available through Monarchinitiative.org and may include mechanistic disease links, patient-data curation, and model evaluations.
Track-two examples include first-in-human dose rationales, biomarker discovery from natural-history data, and regulatory dossier review for bespoke therapies.
Source and freshness
- Source
- anthropic.com
- Published
- Added to Yomu
Summaries are generated from the original by a language model. Check the original before relying on it.
Keep reading
Related reading
The Good Stuff
Paid picks we use ourselves. Links carry a referral code — a subscription through one earns us a commission at no extra cost to you.
The best engineering reads, once a week
One useful email. Unsubscribe anytime.